CVS Mark - Search News

CVS, Cigna and UnitedHealth

CNN on MSN · 1d

FTC finds middlemen inflate specialty generic drug prices by billions of dollars

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,

Quartz on MSN · 1d

CVS, Cigna, and UnitedHealth inflated cancer and HIV drug prices, FTC says

Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 billion in revenue, The Federal Trade Commission (FTC) said in a report released today.

Investing.com on MSN · 1d

FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down

Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing

Managed Healthcare Executive22h

New FTC Report: PBMs Mark Up Specialty Generic Drugs

The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...

3don MSN

CVS Health stock price rises after Walgreens earnings: is it a buy?

The CVS Health stock price rebounded to $48 on Monday, up 10% from its lowest in December. This rebound continued after the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results